Key result
Preparticipation screening detects training-unrelated ECG abnormalities in ~12% of male African athletes.
Why the study?
Preparticipation cardiovascular screening is advocated to reduce sudden cardiac death in Caucasian athletes, but its feasibility and efficiency in native African athletes remain uncertain.
Does preparticipation cardiovascular screening identify cardiovascular abnormalities in native African athletes?
Cross-Sectional (n=210)
Does preparticipation cardiovascular screening identify cardiovascular abnormalities in native African athletes?
Preparticipation cardiovascular screening in native African athletes identifies training-unrelated ECG abnormalities in approximately 12% and structural abnormalities in 5%, though conclusive diagnosis remains challenging in developing settings.
Answers are grounded in this paper and cite their sources.
May warrant targeted screening in African athletes; extends sparse data but leaves open need for prospective validation.
AIMS: Preparticipation cardiovascular (CV) screening has been advocated as an efficient strategy to reduce sudden cardiac death in Caucasian athletes. At present, uncertainty remains if such strategy is feasible and efficient in native African athletes. To this scope, we performed a CV screening in an African setting. METHODS: 210 male Gabonian football players were examined with history, physical examination, ECG and echocardiography. RESULTS: On history, 19 players (9%) referred atypical chest discomfort/oppression. Familial sudden death was referred by 36 (17%). No anomalies were detected at physical examination. ECG showed large proportions of 'training-related' abnormalities, that is, ST-segment elevation in precordial leads in 150 (71.4%), and isolated increase in R/S-wave voltage in 116 (55.2%). A substantial subset (12.4%) showed 'training-unrelated' abnormalities, that is, inverted T-waves in 10 (4.8%), left atrial enlargement in 8 (4%), deep Q-waves in 3 (1.4%). On echocardiography, one athlete meet criteria for hypertrophic cardiomyopathy (HCM); none showed evidence for arrhythmogenic right ventricular cardiomyopathy (ARVC) or dilated cardiomyopathy (DCM). Other abnormalities included mitral valve prolapse in three, atrial septal defect in two and pulmonary hypertension in one. CONCLUSIONS: About 12% of native African athletes showed ECG abnormalities unrelated to training and requiring additional testing and periodical follow-up. Structural abnormalities were found, however, in a minority (5%), including HCM in one, but no ARVC or DCM. In conclusion, this study demonstrates that preparticipation CV screening is efficient to identify (or raise suspicion) for CV abnormalities in native African athletes, but challenging for conclusive identification of cardiac diseases in the difficult scenario of a developing African country.
No takes yet. Share an insight, caveat, or question.
Schmied et al. (2013) conducted a cross-sectional in Cardiovascular disease (n=210). Preparticipation cardiovascular screening was evaluated on Training-unrelated ECG abnormalities and structural cardiac abnormalities. Preparticipation cardiovascular screening in male African athletes identified training-unrelated ECG abnormalities in 12.4% and structural cardiac abnormalities in 5%.
Synapse has enriched 10 related papers. Consider them for comparative context: